241 related articles for article (PubMed ID: 32777554)
1. Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis.
Gerussi A; Bernasconi DP; O'Donnell SE; Lammers WJ; Van Buuren H; Hirschfield G; Janssen H; Corpechot C; Reig A; Pares A; Battezzati PM; Zuin MG; Cazzagon N; Floreani A; Nevens F; Gatselis N; Dalekos G; Mayo MJ; Thorburn D; Bruns T; Mason AL; Verhelst X; Kowdley K; van der Meer A; Niro GA; Beretta-Piccoli BT; Marzioni M; Belli LS; Marra F; Valsecchi MG; Lindor KD; Invernizzi P; Hansen BE; Carbone M;
Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1688-1697.e14. PubMed ID: 32777554
[TBL] [Abstract][Full Text] [Related]
2. Contributing factors and outcomes of burn-associated cholestasis.
de Tymowski C; Dépret F; Soussi S; Nabila M; Vauchel T; Chaussard M; Benyamina M; Ferry A; Cupaciu A; Jully M; Oueslati H; Fratani A; Coutrot M; Sogni P; Mimoun M; Chaouat M; Zagdanski AM; De Kerviler E; Mebazaa A; Moreau R; Mallet V; Legrand M;
J Hepatol; 2019 Sep; 71(3):563-572. PubMed ID: 31152758
[TBL] [Abstract][Full Text] [Related]
3. Primary biliary cholangitis with normal alkaline phosphatase: A neglected clinical entity challenging current guidelines.
Terziroli Beretta-Piccoli B; Stirnimann G; Mertens J; Semela D; Zen Y; Mazzucchelli L; Voreck A; Kolbus N; Merlo E; Di Bartolomeo C; Messina P; Cerny A; Costantini S; Vergani D; Mieli-Vergani G;
J Autoimmun; 2021 Jan; 116():102578. PubMed ID: 33229138
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of peripheral blood Gamma-glutamyl transferase in different liver diseases.
Xing M; Gao M; Li J; Han P; Mei L; Zhao L
Medicine (Baltimore); 2022 Jan; 101(1):e28443. PubMed ID: 35029891
[TBL] [Abstract][Full Text] [Related]
5. Setanaxib, a first-in-class selective NADPH oxidase 1/4 inhibitor for primary biliary cholangitis: A randomized, placebo-controlled, phase 2 trial.
Invernizzi P; Carbone M; Jones D; Levy C; Little N; Wiesel P; Nevens F;
Liver Int; 2023 Jul; 43(7):1507-1522. PubMed ID: 37183520
[TBL] [Abstract][Full Text] [Related]
6. Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival.
Montano-Loza AJ; Hansen BE; Corpechot C; Roccarina D; Thorburn D; Trivedi P; Hirschfield G; McDowell P; Poupon R; Dumortier J; Bosch A; Giostria E; Conti F; Parés A; Reig A; Floreani A; Russo FP; Goet JC; Harms MH; van Buuren H; Van den Ende N; Nevens F; Verhelst X; Donato MF; Malinverno F; Ebadi M; Mason AL;
Gastroenterology; 2019 Jan; 156(1):96-107.e1. PubMed ID: 30296431
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin M: A Neglected Serum Biomarker in Treatment-Naive Primary Biliary Cholangitis With Normal Alkaline Phosphatase.
Ding D; Xuan G; Hu Y; Yu J; Liu Y; Guo G; Ma S; Yang F; Tian S; Ma G; Chen L; Zhou X; Shang Y; Han Y
Hepatol Commun; 2022 Jun; 6(6):1403-1412. PubMed ID: 35182047
[TBL] [Abstract][Full Text] [Related]
8. Role of ductular reaction and ductular-canalicular junctions in identifying severe primary biliary cholangitis.
Overi D; Carpino G; Cristoferi L; Onori P; Kennedy L; Francis H; Zucchini N; Rigamonti C; Viganò M; Floreani A; D'Amato D; Gerussi A; Venere R; Alpini G; Glaser S; Alvaro D; Invernizzi P; Gaudio E; Cardinale V; Carbone M
JHEP Rep; 2022 Nov; 4(11):100556. PubMed ID: 36267871
[TBL] [Abstract][Full Text] [Related]
9. Farnesoid X receptor agonist tropifexor attenuates cholestasis in a randomised trial in patients with primary biliary cholangitis.
Schramm C; Wedemeyer H; Mason A; Hirschfield GM; Levy C; Kowdley KV; Milkiewicz P; Janczewska E; Malova ES; Sanni J; Koo P; Chen J; Choudhury S; Klickstein LB; Badman MK; Jones D
JHEP Rep; 2022 Nov; 4(11):100544. PubMed ID: 36267872
[TBL] [Abstract][Full Text] [Related]
10. Real-world experience with obeticholic acid in patients with primary biliary cholangitis.
D'Amato D; De Vincentis A; Malinverno F; Viganò M; Alvaro D; Pompili M; Picciotto A; Palitti VP; Russello M; Storato S; Pigozzi MG; Calvaruso V; De Gasperi E; Lleo A; Castellaneta A; Pellicelli A; Cazzagon N; Floreani A; Muratori L; Fagiuoli S; Niro GA; Feletti V; Cozzolongo R; Terreni N; Marzioni M; Pellicano R; Pozzoni P; Baiocchi L; Chessa L; Rosina F; Bertino G; Vinci M; Morgando A; Vanni E; Scifo G; Sacco R; D'Antò M; Bellia V; Boldizzoni R; Casella S; Omazzi B; Poggi G; Cristoferi L; Gerussi A; Ronca V; Venere R; Ponziani F; Cannavò M; Mussetto A; Fontana R; Losito F; Frazzetto E; Distefano M; Colapietro F; Labanca S; Marconi G; Grassi G; Galati G; O'Donnell SE; Mancuso C; Mulinacci G; Palermo A; Claar E; Izzi A; Picardi A; Invernizzi P; Carbone M; Vespasiani-Gentilucci U;
JHEP Rep; 2021 Apr; 3(2):100248. PubMed ID: 33681748
[TBL] [Abstract][Full Text] [Related]
11. Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid.
de Veer RC; Harms MH; Corpechot C; Thorburn D; Invernizzi P; Janssen HLA; Battezzati PM; Nevens F; Lindor KD; Floreani A; Ponsioen CY; Mayo MJ; Parés A; Mason AL; Kowdley KV; Trivedi PJ; Hirschfield GM; Bruns T; Dalekos GN; Gatselis NK; Verhelst X; Lammers WJ; Hansen BE; van Buuren HR; van der Meer AJ;
Aliment Pharmacol Ther; 2022 Nov; 56(9):1408-1418. PubMed ID: 36138566
[TBL] [Abstract][Full Text] [Related]
12. Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis.
Yamashita Y; Umemura T; Kimura T; Joshita S; Hirohara J; Nakano T; Komori A; Tanaka A
JHEP Rep; 2023 Apr; 5(4):100662. PubMed ID: 36873419
[TBL] [Abstract][Full Text] [Related]
13. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis.
Harms MH; van Buuren HR; Corpechot C; Thorburn D; Janssen HLA; Lindor KD; Hirschfield GM; Parés A; Floreani A; Mayo MJ; Invernizzi P; Battezzati PM; Nevens F; Ponsioen CY; Mason AL; Kowdley KV; Lammers WJ; Hansen BE; van der Meer AJ
J Hepatol; 2019 Aug; 71(2):357-365. PubMed ID: 30980847
[TBL] [Abstract][Full Text] [Related]
14. Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase.
Murillo Perez CF; Harms MH; Lindor KD; van Buuren HR; Hirschfield GM; Corpechot C; van der Meer AJ; Feld JJ; Gulamhusein A; Lammers WJ; Ponsioen CY; Carbone M; Mason AL; Mayo MJ; Invernizzi P; Battezzati PM; Floreani A; Lleo A; Nevens F; Kowdley KV; Bruns T; Dalekos GN; Gatselis NK; Thorburn D; Trivedi PJ; Verhelst X; Parés A; Janssen HLA; Hansen BE;
Am J Gastroenterol; 2020 Jul; 115(7):1066-1074. PubMed ID: 32618657
[TBL] [Abstract][Full Text] [Related]
15. Increased intercellular adhesion molecule-1 serum concentration in cholestasis.
Polzien F; Ramadori G
J Hepatol; 1996 Dec; 25(6):877-86. PubMed ID: 9007716
[TBL] [Abstract][Full Text] [Related]
16. Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study.
Lammers WJ; van Buuren HR; Hirschfield GM; Janssen HL; Invernizzi P; Mason AL; Ponsioen CY; Floreani A; Corpechot C; Mayo MJ; Battezzati PM; Parés A; Nevens F; Burroughs AK; Kowdley KV; Trivedi PJ; Kumagi T; Cheung A; Lleo A; Imam MH; Boonstra K; Cazzagon N; Franceschet I; Poupon R; Caballeria L; Pieri G; Kanwar PS; Lindor KD; Hansen BE;
Gastroenterology; 2014 Dec; 147(6):1338-49.e5; quiz e15. PubMed ID: 25160979
[TBL] [Abstract][Full Text] [Related]
17. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid.
Kuiper EM; Hansen BE; de Vries RA; den Ouden-Muller JW; van Ditzhuijsen TJ; Haagsma EB; Houben MH; Witteman BJ; van Erpecum KJ; van Buuren HR;
Gastroenterology; 2009 Apr; 136(4):1281-7. PubMed ID: 19208346
[TBL] [Abstract][Full Text] [Related]
18. Obeticholic acid for the treatment of primary biliary cholangitis.
Ali AH; Lindor KD
Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
[TBL] [Abstract][Full Text] [Related]
19. Serum cholestasis markers as predictors of early outcome after liver transplantation.
Ben-Ari Z; Weiss-Schmilovitz H; Sulkes J; Brown M; Bar-Nathan N; Shaharabani E; Yussim A; Shapira Z; Tur-Kaspa R; Mor E
Clin Transplant; 2004 Apr; 18(2):130-6. PubMed ID: 15016125
[TBL] [Abstract][Full Text] [Related]
20. [The effect of Cathepsin S in primary biliary cholangitis].
Luo X; Li X; Du ZR; Peng Y; Deng CW; Fei YY
Zhonghua Yi Xue Za Zhi; 2019 Feb; 99(7):505-509. PubMed ID: 30786347
[No Abstract] [Full Text] [Related]
[Next] [New Search]
